News Center - View Videos, Articles, & Resources

Featured Articles

Suzanne Ostrander, Head of Clinical Operations at Prothena, answers questions about Prothena’s new partnership with Walgreens

June 06, 2023

Q: Why is Prothena partnering with Walgreens? A: Our collaboration with Walgreens should accelerate patient identification and increase access and recruitment for Prothena’s ongoing ASCENT-2 multiple ascending dose clinical trial, which is evaluating the safety and tolerability of PRX012. PRX012 is a potential best-in-class anti-Aβ antibody under development for the treatment of Alzheimer’s disease […]

Prothena joins Rare Disease Company Coalition (RDCC)

April 11, 2023

Prothena recently joined the Rare Disease Company Coalition, a coalition of companies dedicated to discovering, developing, and delivering rare disease treatments for the patients we collectively serve. “We are happy to welcome Prothena to the Coalition; they join us in our work to advocate for policies that enable positive changes to be realized for the […]

Hear from Prothenians as they share their perspectives on what Rare Disease Day means to them

March 13, 2023

Press Releases

Date	Title
Jun 02, 2023	Prothena to Participate in Jefferies 2023 Healthcare Conference
May 16, 2023	Prothena Announces Appointment of Billy Dunn, M.D., to its Board of Directors
May 04, 2023	Prothena Reports First Quarter 2023 Financial Results and Business Highlights
Apr 27, 2023	Prothena to Report First Quarter 2023 Financial Results on May 4
Apr 24, 2023	Prothena to Participate in 2023 Bank of America Healthcare Conference
Apr 13, 2023	Walgreens and Prothena Partner to Increase Access and Enrollment in Alzheimer’s Disease Clinical Trial
Mar 31, 2023	Prothena Presents New Preclinical Data Supporting Best-in-Class Profile of PRX012, a Next-Generation Anti-Amyloid Beta Antibody, at AD/PD 2023
Mar 21, 2023	Prothena to Participate in Stifel 2023 Virtual CNS Days
Mar 14, 2023	Prothena to Highlight Next Generation Treatments for Alzheimer’s and Parkinson’s Disease at the AD/PD 2023 Meeting
Feb 23, 2023	Prothena Reports Fourth Quarter and Full Year 2022 Financial Results, and Provides Financial Guidance and Business Highlights